Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome;Miyofasiyal aǧri sendromlu hastalarin tedavisinde non-invazif ve invazif tekniklerin karsi̧laştinlmasi

Agri

Volumn 21, Issue 3, 2009, Pages 104-112

  Gül, Kürşat ^a   Onal, Ateş Selami ^b  

^a Bingol State Hospital   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Botulinum toxin A trigger point injection; Fldocaine; Laser; Myofascial pain syndrome; TENS

Indexed keywords

BOTULINUM TOXIN A; LIDOCAINE; LOCAL ANESTHETIC AGENT; MUSCLE RELAXANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MALE; MIDDLE AGED; MYOFASCIAL PAIN; RANDOMIZED CONTROLLED TRIAL; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANESTHETICS, LOCAL; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; LASER THERAPY; LIDOCAINE; MALE; MIDDLE AGED; MYOFASCIAL PAIN SYNDROMES; NEUROMUSCULAR AGENTS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70249145430     PISSN: 13000012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil 1998, 79:863-872
2. Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician 2002;65:653-660
3. Aydin R, Şen N, Ellialtioǧlu A. Eklem dişt romatizmal hastahklar. In: Diniz F, Ketenci A, editors. Fiziksel tip ve reha-bilitasyon. Istanbul: Nobel Tip Kitabevi; 2000. p. 299-320.
4. Borg-Stein J, Simons DG. Myofascial pain. Arch Phys Med Rehabil 2002;83(Suppl 1):40-47.
5. Bal S, Çeliker R. Baş ve boyun (Miyofasyal Aǧri Sendromu). In: Gökçe-Kutsal Y, editors. Yumuşak doku romatizmalari. Ankara: Günes Kitabevi; 2002. p. 1-12.
6. Uyar M. Miyofasiyal aǧri sendromu ve diǧer musküloskeletal kökenli ag̈rilar. In: Erdine S, editor. Aǧri. Istanbul: Nobel Tip Kitabevleri; 2000. p. 387-396
7. Göktepe S. Laser. Elektroterapi. In: Tuna N, editor. Istanbul: Nobel Tip Kitabevleri; 2001. p. 155-162
8. Fischer AA. New approaches in treatment of myofascial pain. Phys Med Rehabil Clin North Am 1997;8:153-169
9. Graff-Radford SB, Reeves JL, Baker RL, Chiu D. Effects of transcutaneous electrical nerve stimulation on myofascial pain and trigger point sensitivity. Pain 1989;37:1-5.
10. Gam AN, Warming S, Larsen LH, Jensen B, Hoøydalsmo O, Alton I, et al. Treatment of myofascial trigger-points with ultrasound combined with massage and exercise-a randomised controlled trial. Pain 1998;77:73-79
11. Yaltkaya K, Nuzumlali D. Olaya ilişkin endojen potansiyeller. Klinik Nörofizyoloji, EEG-EMG Derneǧi yayinlari No: 2, Izmir: 1994.
12. Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994;59:65-69
13. Cooper BC, Alleva M, Cooper DL, Lucente FE. Myofacial pain dysfunction: analysis of 476 patients. Laryngoscope 1986;96:1099-1106
14. Fischer AA. Documentation of myofascial trigger points. Arch Phys Med Rehabil 1988;69:286-291
15. Roth RS, Horowitz K, Bachman JE. Chronic myofascial pain: knowledge of diagnosis and satisfaction with treatment. Arch Phys Med Rehabil 1998;79:966-970 (Pubitemid 20734110)
16. Fricton JR, Auvinen MD, Dykstra D, Schiffman E. Myofascial pain syndrome: electromyographic changes associated with local twitch response. Arch Phys Med Rehabil 1985;66:314-317
17. Hong CZ, Hsueh TC. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 1996;77:1161-1166
18. CummingsTM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 2001;82:986-992
19. Fishbain DA, Goldberg M, Steele R, Rosomoff H. DSM-III diagnoses of patients with myofascial pain syndrome (fibrositis). Arch Phys Med Rehabil 1989;70:433-438
20. Gunn CC. The Gunn approach to the treatment of chronic pain; intramuscular stimulation for myofascial pain of radiculopathic originNew York: Churchill Livingston; 1996. p. 11-37.
21. Çirpanh G. Miyofasiyal aǧri sendromunun tedavisinde tran-skütanöz elektriksel sinir stimülasyonunun etkisi. [Uzmanhk Tezi] Bursa Uludaǧ Üniversitesi Tip Fakültesi FTR Bölüimü, 1997.
22. Han SC, Harrison P. Myofascial pain syndrome and trigger- point management. Reg Anesth 1997;22:89-101.
23. Fricton JR. Clinical care for myofascial pain. Dent Clin North Am 1991;35:1-28.
24. Önal A (editor). Algoloji. Istanbul: Nobel Tip Kitabevleri; 2004. p. 185-186
25. Simunovic Z. Low level laser therapy with trigger points technique: a clinical study on 243 patients. J Clin Laser Med Surg 1996;14:163-167
26. Hakgüder A, Birtane M, Gürcan S, Kokino S, Turan FN. Efficacy of low level laser therapy in myofascial pain syndrome: an algometric and thermographic evaluation. Lasers Surg Med 2003;33:339-343
27. Gur A, Sarac AJ, Cevik R, Altindag O, Sarac S. Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: a double-blind and randomize-controlled trial. Lasers Surg Med 2004;35:229-235
28. Dundar U, Evcik D, Samli F, Pusak H, Kavuncu V. The effect of gallium arsenide aluminum laser therapy in the management of cervical myofascial pain syndrome: a double blind, placebo-controlled study. Clin Rheumatol 2007;26:930-934
29. Kadi F, Waling K, Ahlgren C, Sundelin G, Holmner S, Butler-Browne GS, et al. Pathological mechanisms implicated in localized female trapezius myalgia. Pain 1998;78:191-196
30. Fine PG, Milano R, Hare BD. The effects of myofascial trigger point injections are naloxone reversible. Pain 1988;32:15-20.
31. Rengin G, Halil A, Gulsah Ş, Şükrü U, Erkan K, Tunay S. Mi-yofasiyal Aǧri Sendromunun Tedavisinde Lokal Anestezik Enjeksiyonu ve Kuru iǧneleme Yǒntemlerinin Etkinliginin Karşilaştinlmasi. Türk Fiz Tip Rehab Derg 2006;52(Özel sayi):22-27.
32. Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine (Phila Pa 1976) 1989;14:962-964
33. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85:101-105
34. Çam-Çelikel F. Kronik aǧri, depresyon, anksiyete ve somatoform bozukluklar. In: Mete HE, editor. Dahiliye ve psikiyatri IV. Istanbul: Okuyan Us Yayin; 2003. p. 9-29.